PennyStock101
Long

$RTTR 40% RALLY SO FAR THIS WEEK. ON WATCHLIST.

NASDAQ:RTTR   RITTER PHARMACEUTICALS INC
The company just announced that the final patient in its Phase 3 clinical trial evaluating RP-G28 for the potential treatment of lactose intolerance has completed the 30-day treatment period. Topline data should be available in early Q4. Look for continuation tomorrow, huge potential gains.

Company Description
Ritter Pharmaceuticals , Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28.
Your Intro To Penny Stock Trading Success...

Sign Up for our 100% Free Email Newsletter:
http://www.PennyStock101.org

Text Message Alerts ---> text 'PS101' to 67076
(It's FREE, however Msg&Data rates may apply.)
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out